Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

CAT and Merck & Co. form HIV alliance

Oct. 15, 2001

VaxGen receives further funding from NIH for HIV vaccine development

Oct. 10, 2001

Potent, selective and orally bioavailable CCR5 antagonist obtained at Schering-Plough

Oct. 8, 2001

Sch-351125: an orally bioavailable anti-HIV CCR5 antagonist

Oct. 4, 2001

Valcyte heading for pan-European approval in mid-2002

Oct. 2, 2001

Chimeric gp41 molecule inhibits HIV fusion at nanomolar concentrations

Sep. 28, 2001

HIV reverse transcriptase inhibitors described by Pfizer team

Sep. 27, 2001

New anti-HIV agents with low cytotoxicity

Sep. 25, 2001

IND filing expected soon for Myriad anti-HIV compound based on positive preclinical data

Sep. 21, 2001

HIV vaccine candidate evaluated in phase I trials

Sep. 20, 2001